Loading...
XLON
WWH
Market cap1.99bUSD
Dec 05, Last price  
383.00GBP
1D
0.66%
1Q
12.48%
Jan 2017
80.92%
Name

Worldwide Healthcare Trust PLC

Chart & Performance

D1W1MN
XLON:WWH chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.55%
Shrs. gr., 5y
57.74%
Rev. gr., 5y
6.45%
Revenues
-198m
L
100,164,000-29,914,000-11,930,00068,481,00085,894,00015,312,00063,311,000113,954,000133,930,000342,158,000-81,112,000252,021,00032,195,000172,070,00096,258,000484,372,000-132,467,000-2,233,000235,192,000-198,056,000
Net income
-210m
L
93,627,000-36,244,000-16,520,00064,263,00079,402,00010,676,00055,312,000112,206,000132,123,000338,687,000-84,629,000248,369,00027,179,000166,240,00090,776,000477,018,000-141,526,000-8,787,000201,162,000-209,768,000
CFO
-2m
L
3,404,0003,585,000479,000-5,823,00000002,115,000931,000-13,329,0005,394,0002,262,000-1,544,000
Dividend
Jun 13, 20242.1 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.
URL
https://www.worldwidewh.com/
IPO date
Apr 06, 1995
Employees
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT